Wells Fargo & Company Rvl Pharmaceuticals PLC Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.08 - $0.55 $0 - $5	10 Added 0.07%	15,246 $1,000
Q2 2023 Aug 15, 2023	BUY	$0.56 - $1.17 $5 - $11	10 Added 0.07%	15,236 $8,000
Q1 2023 May 12, 2023	SELL	$1.02 - $1.39 $1,526 - $2,080	-1,497 Reduced 8.95%	15,226 $17,000
Q4 2022 Feb 13, 2023	SELL	$1.02 - $1.61 $7,133 - $11,260	-6,994 Reduced 29.49%	16,723 $18,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $2.91 $200 - $456	-157 Reduced 0.66%	23,717 $49,000
Q2 2022 Aug 12, 2022	BUY	$1.21 - $1.81 $27 - $41	23 Added 0.1%	23,874 $32,000
Q1 2022 May 16, 2022	BUY	$1.03 - $2.01 $104 - $203	101 Added 0.43%	23,851 $40,000
Q4 2021 Feb 14, 2022	BUY	$0.98 - $3.06 $6,605 - $20,624	6,740 Added 39.62%	23,750 $25,000
Q3 2021 Nov 15, 2021	BUY	$2.79 - $4.19 $27,900 - $41,900	10,000 Added 142.65%	17,010 $50,000
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $24,984 - $33,728	-8,923 Reduced 56.0%	7,010 $21,000
Q1 2021 May 13, 2021	SELL	$3.26 - $4.84 $4,577 - $6,795	-1,404 Reduced 8.1%	15,933 $52,000
Q4 2020 Feb 09, 2021	SELL	$4.12 - $6.29 $42,732 - $65,239	-10,372 Reduced 37.43%	17,337 $71,000
Q3 2020 Nov 05, 2020	BUY	$4.82 - $8.77 $80,884 - $147,169	16,781 Added 153.56%	27,709 $150,000
Q2 2020 Aug 13, 2020	SELL	$2.83 - $6.99 $1,259 - $3,110	-445 Reduced 3.91%	10,928 $74,000
Q1 2020 May 14, 2020	BUY	$3.18 - $7.0 $36,166 - $79,611	11,373 New	11,373 $36,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.